Search Results 1531-1540 of 20828 for Informed consent

1. Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Written informed consent obtained from the patient/legal representative;; Histologically confirmed recurrent or metastatic SCCHN; tumor progression or ...

2. Multi-Center Prospective Validation Study of VTE Risk Prediction Tool in Trauma Patients - Mayo Clinic

   Subjects meeting all of the above criteria but who are pregnant will also be enrolled but will first require informed consent prior to blood draws. Exclusion ...

3. Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma - Mayo Clinic

   ... informed consent and authorization to use protected health information. Exclusion Criteria: * Prior systemic treatment for mantle cell lymphoma. Short course ...

4. Epidemiology of Chronic Lymphocytic Leukemia Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

   Providing permission with written informed consent to access, for research purposes only, any medical records related to care for blood or lymph node cancer or ...

5. Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System - Mayo Clinic

   Patient has signed the informed consent. Exclusion Criteria: Patients with known Inflammatory Bowel Disease and / or active Colitis. Patients with active ...

6. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors - Mayo Clinic

   Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal ...

7. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting - Mayo Clinic

   Participation eligibility · Willing and able to provide written informed consent, (individuals ≥ 18 years of age) or assent (individuals ≥ 12 and < 18 years of ...

8. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Subjects must understand and voluntarily sign written informed consent obtained prior to any study procedure/assessment being conducted. Willing and able to ...

9. Understanding Reasons for Emergence and Persistence of Inflammation - Mayo Clinic

   Participation eligibility · Male or female ≥ 18 years. · Provision of signed and dated informed consent form (may be completed by legal authorized representative ...

10. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

    Aged 18 years or older at the time of consent; Able to give informed consent. Subjects with high grade BCG-refractory or relapsed NMIBC including. High grade ...